Evidence map›Paper›PMID 38110350›Full record

ArticleCell death & disease2023

Correction: MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function.

Zhipeng Li, Huaxin Zhou, Xiangyu Zhai, Lin Gao, Mengfan Yang, Baokun An, Tong Xia, Gang Du, Xiaoming Li, Wei Wang and 1 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Zhipeng Li *Department of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China.
Huaxin Zhou *Department of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China.
Xiangyu Zhai *Department of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China.
Lin GaoDepartment of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China.
Mengfan YangOrgan Transplant Department, Qilu Hospital of Shandong University, Jinan, China.
Baokun AnDepartment of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China.
Tong XiaOrgan Transplant Department, Qilu Hospital of Shandong University, Jinan, China.
Gang DuOrgan Transplant Department, Qilu Hospital of Shandong University, Jinan, China.
Xiaoming LiDepartment of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China. l15288840712@163.com.
Wei WangMedical integration and practice center of Shandong University, Jinan, China. jinglewei@sdu.edu.cn.
Bin JinDepartment of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China. jinbin9449@126.com.ORCID http://orcid.org/0000-0002-1411-2631
Second Hospital of Shandong University · CNQilu Hospital of Shandong University · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38110350
PMCPMC10728062
OpenAlexW4389881995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.